Available to sourceHuman Prescription DrugGastrointestinal

sodium chloride

9 mg/mL · Injection Solution

By Medefil, Inc.

NDC: 64253-202
Route: Intramuscular; Intravenous; Subcutaneous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.